Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of SAbR for Patients With Oligometastatic Renal Cell Carcinoma

NCT02956798 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT02956798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02956798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of SAbR for Patients With Oligometastatic Renal Cell Carcinoma
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Not applicable
Overall status
Completed
Start date
July 19, 2018
Completion date
January 24, 2024
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic renal cell carcinoma